CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth

This item is shared privately

dataset

modified on 2023-05-06, 12:21

original data

Funding

Science and Technology Planning Project of Guangzhou 202201010005

National Natural Science Foundation of China 31771578

Innovation and university promotion project of Guangdong Pharmaceutical University 2017KCXTD020

Project of Administration of Traditional Chinese Medicine of Guangdong Province of China 20202106

John D. Stobo, M.D. Distinguished Chair Endowment Fund at UTMB

Categories

Basic pharmacology

Keywords

CYD0281 angiogenesis

Licence